STOCK TITAN

KIORA PHARM WTS 9/27/27 (KPHMW) Net Income by Year

KPHMW

KIORA PHARM WTS 9/27/27 reported a net loss of $10.8M in fiscal year 2025. This represents a decrease of 401.4% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters KIORA PHARM WTS 9/27/27 has filed alongside them.

FY2025 annual
Net Income -$10.8M
YoY -401.4%
5Y CAGR n/m
10Y CAGR n/m
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KPHMW Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$10.8M-401.4%$3.6Mn/m-$12.5Mn/m-$13.6Mn/m-$13.8Mn/m-$6.9Mn/m-$7.1Mn/m-$10.8Mn/m-$13.2Mn/m-$13.3Mn/m-$8.4Mn/m-$1.8M

KPHMW Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$2.1Mn/m-$2.4Mn/mN/A$27Kn/m-$2.2Mn/m-$2.2M-116.3%N/A-$3.4Mn/m-$2.2Mn/m$13.5Mn/mN/A-$5.8Mn/m

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More KIORA PHARM WTS 9/27/27 financials

Frequently Asked Questions

What was KIORA PHARM WTS 9/27/27's net income in fiscal year 2025?

KIORA PHARM WTS 9/27/27 reported a net loss of $10.8M in fiscal year 2025.

How fast is KIORA PHARM WTS 9/27/27's net income growing?

KIORA PHARM WTS 9/27/27 (KPHMW) net income fell by 401.4% year over year, from $3.6M to -$10.8M in fiscal year 2025.

How has KIORA PHARM WTS 9/27/27's net income changed over the years?

Across the 12 fiscal years this page covers, KIORA PHARM WTS 9/27/27 (KPHMW) net income went from -$1.8M in fiscal year 2014 to -$10.8M in fiscal year 2025.

KIORA PHARM WTS 9/27/27 (KPHMW) reported -$2.1M in net income in Q2 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what KIORA PHARM WTS 9/27/27 (KPHMW) reported on that line in every period on record.